http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111235032-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e38d2869e2e7a31bb243062c07b259c0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L9-015
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L9-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M3-00
filingDate 2020-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_843f07109622bfaadc4eae016f5fe54c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c93f8847f6648701534b0a84204bc80
publicationDate 2020-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111235032-A
titleOfInvention Sterile system for stem cell/immune cell production and system control method
abstract The invention relates to a sterile system for stem cell/immune cell production and a system control method, belonging to the technical field of biology. The invention solves the problems of insufficient control, overhigh energy consumption of sterile environment and unreasonable design of the existing sterile system for stem cell/immune cell production. The invention includes sterile isolation zones for stem cell/immune cell production; the sterile isolation area is provided with a personnel channel for the inlet and outlet of operators and a logistics channel for the inlet and outlet of product materials; the top of the sterile isolation area is provided with an air inlet pipeline mechanism, and the lower part of the sterile isolation area is provided with an air return pipeline; the air inlet pipeline mechanism comprises an air supplementing pipeline, an ozone generator and a VHP generator are arranged on the air supplementing pipeline, a fan is communicated with the air supplementing pipeline, and the air returning pipeline is communicated with the air supplementing pipeline.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114311670-A
priorityDate 2020-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24823

Total number of triples: 35.